FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3014134003> ?p ?o ?g. }

• W3014134003 endingPage "2805" @default.
• W3014134003 startingPage "2795" @default.
• W3014134003 abstract "Long non-coding RNAs (lncRNAs) participate in a series of pathological processes in tumorigenesis. Reports show that C5orf66-AS1, an antisense lncRNA, is expressed in various tumors. However, the role of C5orf66-AS1 in gastric cancer (GC) has not been fully clarified. The study focused on the expression patterns and serum level of C5orf66-AS1 in GC to explore its potential application in GC screening and diagnosis. The effects of C5orf66-AS1 on GC cells were also analyzed.Tissue and serum samples were used for RNA isolation. Expression levels of C5orf66-AS1 in GC tissues, serum, and cell lines were detected using quantitative real-time reverse transcription-polymerase chain reaction (qRT-PCR). CCK-8, transwell, and wound healing assays were performed to determine the effects of C5orf66-AS1 on GC cell behavior.C5orf66-AS1 expression was downregulated in GC cells compared to that in adjacent normal tissues. Serum C5orf66-AS1 levels were significantly lower in GC patients than in superficial gastritis (GS) and atrophic gastritis (GA) patients. Low serum expression of C5orf66-AS1 was associated with an increased risk of gastric dysplasia (GD) and GC. Receiver operating characteristic curve results showed that the area under curve (AUC) for GC was 0.688, with a sensitivity and specificity of 77.5% and 53.6%, respectively. For the GD + early gastric cancer (ECG) group, the AUC was 0.789, with a sensitivity and specificity of 85.15% and 62.86%, respectively. Correlation analyses of clinicopathological parameters showed that serum C5orf66-AS1 was predominantly associated with Lauren type, TNM stages, pTNM stages, and vessel tumor emboli. Additionally, in vitro overexpression of C5orf66-AS1 in AGS cells inhibited cell proliferation, migration, and invasion.Decreased expression levels of serum C5orf66-AS1 can be utilized for diagnosis of GC, especially for early diagnosis. The low level of serum C5orf66-AS1 indicated poor biological behavior of tumors in GC patients. In addition, C5orf66-AS1 can inhibit GC cell proliferation, migration, and invasion." @default.
• W3014134003 created "2020-04-10" @default.
• W3014134003 creator A5004318775 @default.
• W3014134003 creator A5011540763 @default.
• W3014134003 creator A5016691739 @default.
• W3014134003 creator A5033611698 @default.
• W3014134003 creator A5040392788 @default.
• W3014134003 date "2020-04-01" @default.
• W3014134003 modified "2023-10-10" @default.
• W3014134003 title "<p>Evaluation of C5orf66-AS1 as a Potential Biomarker for Predicting Early Gastric Cancer and Its Role in Gastric Carcinogenesis</p>" @default.
• W3014134003 cites W1588142016 @default.
• W3014134003 cites W1912683372 @default.
• W3014134003 cites W1984499682 @default.
• W3014134003 cites W1986989569 @default.
• W3014134003 cites W2005143903 @default.
• W3014134003 cites W2022106698 @default.
• W3014134003 cites W2023769072 @default.
• W3014134003 cites W2024399356 @default.
• W3014134003 cites W2028707203 @default.
• W3014134003 cites W2088128227 @default.
• W3014134003 cites W2105349784 @default.
• W3014134003 cites W2124374092 @default.
• W3014134003 cites W2141831115 @default.
• W3014134003 cites W2171000684 @default.
• W3014134003 cites W2172967221 @default.
• W3014134003 cites W2304104352 @default.
• W3014134003 cites W2595012919 @default.
• W3014134003 cites W2615184377 @default.
• W3014134003 cites W2670120864 @default.
• W3014134003 cites W2762025789 @default.
• W3014134003 cites W2786502063 @default.
• W3014134003 cites W2792272990 @default.
• W3014134003 cites W2792603544 @default.
• W3014134003 cites W2794216514 @default.
• W3014134003 cites W2885593234 @default.
• W3014134003 cites W2895153912 @default.
• W3014134003 cites W2903336069 @default.
• W3014134003 cites W2955125732 @default.
• W3014134003 cites W2965238028 @default.
• W3014134003 cites W2968688746 @default.
• W3014134003 cites W4207058970 @default.
• W3014134003 cites W4242852626 @default.
• W3014134003 cites W4247436934 @default.
• W3014134003 cites W4254955532 @default.
• W3014134003 doi "https://doi.org/10.2147/ott.s239965" @default.
• W3014134003 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/7136487" @default.
• W3014134003 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/32308414" @default.
• W3014134003 hasPublicationYear "2020" @default.
• W3014134003 type Work @default.
• W3014134003 sameAs 3014134003 @default.
• W3014134003 citedByCount "13" @default.
• W3014134003 countsByYear W30141340032020 @default.
• W3014134003 countsByYear W30141340032021 @default.
• W3014134003 countsByYear W30141340032022 @default.
• W3014134003 countsByYear W30141340032023 @default.
• W3014134003 crossrefType "journal-article" @default.
• W3014134003 hasAuthorship W3014134003A5004318775 @default.
• W3014134003 hasAuthorship W3014134003A5011540763 @default.
• W3014134003 hasAuthorship W3014134003A5016691739 @default.
• W3014134003 hasAuthorship W3014134003A5033611698 @default.
• W3014134003 hasAuthorship W3014134003A5040392788 @default.
• W3014134003 hasBestOaLocation W30141340031 @default.
• W3014134003 hasConcept C104317684 @default.
• W3014134003 hasConcept C121608353 @default.
• W3014134003 hasConcept C126322002 @default.
• W3014134003 hasConcept C142724271 @default.
• W3014134003 hasConcept C153911025 @default.
• W3014134003 hasConcept C2778677798 @default.
• W3014134003 hasConcept C2779422922 @default.
• W3014134003 hasConcept C2780342937 @default.
• W3014134003 hasConcept C2781197716 @default.
• W3014134003 hasConcept C48023723 @default.
• W3014134003 hasConcept C49105822 @default.
• W3014134003 hasConcept C502942594 @default.
• W3014134003 hasConcept C55493867 @default.
• W3014134003 hasConcept C555283112 @default.
• W3014134003 hasConcept C62203573 @default.
• W3014134003 hasConcept C67705224 @default.
• W3014134003 hasConcept C71924100 @default.
• W3014134003 hasConcept C86803240 @default.
• W3014134003 hasConceptScore W3014134003C104317684 @default.
• W3014134003 hasConceptScore W3014134003C121608353 @default.
• W3014134003 hasConceptScore W3014134003C126322002 @default.
• W3014134003 hasConceptScore W3014134003C142724271 @default.
• W3014134003 hasConceptScore W3014134003C153911025 @default.
• W3014134003 hasConceptScore W3014134003C2778677798 @default.
• W3014134003 hasConceptScore W3014134003C2779422922 @default.
• W3014134003 hasConceptScore W3014134003C2780342937 @default.
• W3014134003 hasConceptScore W3014134003C2781197716 @default.
• W3014134003 hasConceptScore W3014134003C48023723 @default.
• W3014134003 hasConceptScore W3014134003C49105822 @default.
• W3014134003 hasConceptScore W3014134003C502942594 @default.
• W3014134003 hasConceptScore W3014134003C55493867 @default.
• W3014134003 hasConceptScore W3014134003C555283112 @default.
• W3014134003 hasConceptScore W3014134003C62203573 @default.
• W3014134003 hasConceptScore W3014134003C67705224 @default.
• W3014134003 hasConceptScore W3014134003C71924100 @default.
• W3014134003 hasConceptScore W3014134003C86803240 @default.

• next